mecamylamine has been researched along with Dyskinesia, Medication-Induced in 2 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iha, HA | 1 |
| Kunisawa, N | 1 |
| Shimizu, S | 1 |
| Onishi, M | 1 |
| Nomura, Y | 1 |
| Matsubara, N | 1 |
| Iwai, C | 1 |
| Ogawa, M | 1 |
| Hashimura, M | 1 |
| Sato, K | 1 |
| Kato, M | 1 |
| Ohno, Y | 1 |
| Bordia, T | 1 |
| Campos, C | 1 |
| McIntosh, JM | 1 |
| Quik, M | 1 |
2 other studies available for mecamylamine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Mechanism Underlying Organophosphate Paraoxon-Induced Kinetic Tremor.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Gene Expression; Male; M | 2019 |
Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.
Topics: Amphetamine; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Bridged Bicyclo Compo | 2010 |